Yes. Really, what you're trying to do is look at attracting early-stage investors if you're doing a start-up in that space.
On the other area that no one really has alluded to here yet, I'll say just very briefly that if you're starting to look at licensing technologies to large companies, it's a different game. I always say that there's licensing over here and then there's doing spin-off companies and start-ups. For a lot of technologies, especially when you look at drug discoveries or some of these areas where there's a huge amount of capital required up front for an idea, licensing is often a better way to go. Really, this type of activity that I'm talking about here is targeted to start-ups, not to licensing.